Insights

Innovative Therapeutics AOBiome specializes in microbiome-based therapies targeting inflammatory and dermatological conditions, including atopic dermatitis and acne, presenting opportunities to collaborate with clinics and healthcare providers seeking cutting-edge treatments in dermatology and inflammatory care.

Strategic Partnerships The company's recent licensing agreements with Maruho Co. for global development and commercialization of B244 suggest opportunities for joint ventures, licensing, or distribution partnerships with international pharmaceutical companies focusing on dermatology solutions.

Pipeline Expansion AOBiome's active clinical pipeline for conditions like eczema, migraines, and allergic rhinitis indicates potential for partnership in clinical trial development, as well as early adoption opportunities for healthcare providers seeking novel therapies.

Funding & Growth With $30 million in funding and revenue under $10 million, AOBiome is positioned for growth, making it an attractive partner for investors and collaborators interested in microbiome innovation and expanding biotechnological solutions.

Targeted Market The company's focus on microbiome therapeutics for inflammatory and skin conditions aligns with rising market demand, offering sales opportunities through dermatology clinics, wellness centers, and pharmaceutical distributors seeking effective microbiome-based products.

AOBiome Therapeutics, Inc. Tech Stack

AOBiome Therapeutics, Inc. uses 8 technology products and services including Varnish, MySQL, Lodash, and more. Explore AOBiome Therapeutics, Inc.'s tech stack below.

Varnish

Caching

MySQL

Database

Lodash

Javascript Libraries

X-XSS-Protection

Security

HSTS

Security

Gravity Forms

Web Platform Extensions

Contact Form 7

Web Platform Extensions

Apache HTTP Server

Web Servers

AOBiome Therapeutics, Inc. Email Formats	Example	Percentage
FLast@aobiome.com	JDoe@aobiome.com	85%
First@aobiome.com	John@aobiome.com	11%
LFirst@aobiome.com	DJohn@aobiome.com	2%
FirstL@aobiome.com	JohnD@aobiome.com	2%

AOBiome Therapeutics, Inc. Email Formats

Example

Percentage

FLast@aobiome.com

JDoe@aobiome.com

85%

First@aobiome.com

John@aobiome.com

11%

LFirst@aobiome.com

DJohn@aobiome.com

FirstL@aobiome.com

JohnD@aobiome.com

Frequently Asked Questions

Where is AOBiome Therapeutics, Inc.'s headquarters located?

AOBiome Therapeutics, Inc.'s main headquarters is located at 125 Cambridge Park Dr, 5th Floor Cambridge, Massachusetts 02140, US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is AOBiome Therapeutics, Inc.'s phone number?

You can contact AOBiome Therapeutics, Inc.'s main corporate office by phone at

+1-617-401-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is AOBiome Therapeutics, Inc.'s official website and social media links?

AOBiome Therapeutics, Inc.'s official website is aobiome.com and has social profiles on LinkedIn Crunchbase.

What is AOBiome Therapeutics, Inc.'s SIC code NAICS code?

AOBiome Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AOBiome Therapeutics, Inc. have currently?

As of October 2025, AOBiome Therapeutics, Inc. has approximately 16 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Operating Officer & Board Member: J. H.Chief Of Staff & Director Of Program Management: C. L.Vice President Research & Development: A. G.. Explore AOBiome Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does AOBiome Therapeutics, Inc. belong to?

AOBiome Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does AOBiome Therapeutics, Inc. use?

AOBiome Therapeutics, Inc.'s tech stack includes VarnishMySQLLodashX-XSS-ProtectionHSTSGravity FormsContact Form 7Apache HTTP Server.

What is AOBiome Therapeutics, Inc.'s email format?

AOBiome Therapeutics, Inc.'s email format typically follows the pattern of FLast@aobiome.com. Find more AOBiome Therapeutics, Inc. email formats with LeadIQ.

When was AOBiome Therapeutics, Inc. founded?

AOBiome Therapeutics, Inc. was founded in 2013.

AOBiome Therapeutics, Inc.

Biotechnology ResearchUnited States11-50 Employees

AOBiome Therapeutics, Inc. is a Cambridge, MA-based life sciences company focused on transforming human health by developing microbiome-based therapies for local, nasal and systemic inflammatory conditions. Founded in 2012 by PatientsLikeMe founder Jamie Heywood and MIT-trained Chemical Engineer David Whitlock, AOBiome is advancing a pipeline of multiple, clinical-stage therapeutic candidates. The company's portfolio includes multiple clinical-stage programs: a completed Phase 2 study to treat patients with acne vulgaris or acne, a Phase 1b study to treat patients with pediatric eczema (atopic dermatitis), a Phase 2a study to treat patients with adult eczema (atopic dermatitis), a Phase 2 study for the prevention of episodic migraines, and a Phase 1b/2a clinical trial for the treatment of allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications.

Insights

Similar companies to AOBiome Therapeutics, Inc.

The Nue Co.

TULA Skincare

Seed Health

BiomeSense

Mother Dirt